Product complaint # (b)(4).Date sent to the fda: 11/04/2020.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Investigation summary: it was reported that the suture separated.One empty open foil and a cannula with a suture of product code ez10, lot am9069 were received for analysis.During visual inspection of the sample, the scored point was noted broken due to use and the end was cut appears to be by use of surgical instrument.In addition, body fluids were observed on the strand.Standard endoscopic procedures should be followed up to the point of tissue ligation or approximation.The endoloop ligature is then introduced through a cannula.An appropriate surgical instrument is used to grasp and position the tissue.This may involve either pulling the tissue through the loop or encompassing the tissue with the loop.The endoloop ligature tube is then broken at the scored point.This allows the tube to slide over the suture and cinches the loop around the tissue.When the ligature has provided hemostasis the suture is cut behind the knot leaving an appropriate length of suture ¿ear¿.The tube is then removed.Several ligatures may be applied to ensure hemostasis or tissue approximation.It should be noted that as part of our quality process, device is visually inspected and functionally tested during manufacturing to ensure the device meets the required specifications prior to shipment.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|